La Trobe
vukicevic-et-al-2021-wfksizpmfaet.pdf (273.11 kB)
Download file

Real-World Visual Outcomes of Treatment Naive Patients with Diabetic Macular Oedema

Download (273.11 kB)
journal contribution
posted on 2022-01-07, 03:30 authored by Meri VukicevicMeri Vukicevic, Czarina Obtinalla, Nandor Jaross

Aim: The aim of this audit was to determine whether patients with diabetic macular oedema attending a routine clinical practice were able to achieve and maintain the visual outcomes reported by clinical trials.

Methods: A retrospective observational study of 131 treatment-naive eyes of patients attending one suburban and one semi-rural ophthalmology clinic, in or close to Melbourne, Australia. Data were extracted from the Diabetic Macular Oedema module of the Fight Retinal Blindness! Registry1 from 2014 to 2020. Main outcome measures included diabetic retinopathy characteristics at baseline, pre-existing ocular conditions, previous treatments, current treatment given, visual acuity, and central subfield thickness.

Results: The average number of treatment injections was 5.58 in the first 12 months, compared with 5.51 beyond 36 months (p>0.05). Eighty percent of patients had a baseline visual acuity of better than 6/12 and there was a statistically significant improvement in acuity from baseline to Year 1, Year 2 and Year 3 (p<0.05). Baseline central serous thickness was 340.58μm and improved significantly at each time point (p<0.05).

Conclusion: Patients attending this routine clinical practice in the real world were not able to achieve and maintain the visual outcomes reported by the phase 3 clinical trials. This is most likely due to under-treatment and suggests that the dosing schedule for patients with diabetic macular oedema should be re-evaluated.


Publication Date



Australian Orthoptic Journal






Orthoptics Australia



Rights Statement

“Orthoptics Australia is committed to supporting research and open access to publications through the Australian Orthoptic Journal, thereby allowing wide dissemination of academic and clinical work. All digital content produced by the Australian Orthoptic Journal is made available under Creative Commons Licences and copyright stays with the author/s who decide how others can reuse their work.”

Usage metrics